The domestic equity
market traded with smart gains on Thursday bucking the muted trend
seen in other Asian and European markets. Ahead of the expiry of
November F&O series, which expired at the end of the trading
session, investors initiated fresh positions on the benchmark
indices.
The S&P BSE
Sensex ended the day with gains of 182 points, or 0.71 per cent, at
25,958 while the 50-stock barometer Nifty50 closed at 7,884, up 52
points, or 0.6 per cent. Tata Motors and Sun Pharma were the top
gainers on the BSE benchmark, up 5.6 and 4 per cent, respectively.
Shares of Dr Reddy's
Labs closed with losses of 8 per cent after the USFDA suggested that
future approvals of its generic products may be under threat if the
company does not comply with safety regulations.
Shares of Sun Pharma
surged 4 per cent at close, snapping a four-day losing streak, after
the drugmaker informed BSE that its subsidiaries have dropped a plan
to invest in a wind energy project in the US.
Dr Reddy's
Laboratories slumped 10 per cent in trade.
DLF surged over 5
per cent in trade.
Natco Pharma
surged over 13 per cent in trade.
Videocon climbed
over 5 per cent in trade.
Sun Pharma surged
over 4 per cent in trade.
Tata Motors was
up about 2 per cent in trade.
Opto Circuit
rallied over 9 per cent in trade.
Shree Renuka
Sugars dipped about 3 per cent in trade.
SPARC gained over
5 per cent in trade.

No comments:
Post a Comment